Selected research
Market Structure
Global Biomedical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biomedical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biomedical CRO include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv and ChemPartner, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Biomedical CRO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biomedical CRO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biomedical CRO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biomedical CRO market size, projected growth trends, production technologies, key applications, and end-use industries.
Biomedical CRO Segment by Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON Plc
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Biomedical CRO Segment by Type
Preclinical CRO
Clinical CRO
Biomedical CRO Segment by Application
Biological Industry
Medical Industry
Biomedical CRO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomedical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical CRO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biomedical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomedical CRO industry.
Chapter 3: Detailed analysis of Biomedical CRO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomedical CROrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preclinical CRO
- Clinical CRO
Applications
- Biological Industry
- Medical Industry
Companies covered
- Charles River
- Wuxi AppTec
- Labcorp
- Eurofins Scientific
- PPD
- ICON Plc
- Pharmaron
- Inotiv
- ChemPartner
- JOINN Lab
- EVOTEC
- Medicilon
- Crown Bioscience
- Champion Oncology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biomedical CRO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Preclinical CRO
- 1.2.3 Clinical CRO
- 1.3 Market Analysis by Application
- 1.3.1 Global Biomedical CRO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biological Industry
- 1.3.3 Medical Industry
- 1.4 Global Market Growth Prospects
- 1.5 Global Biomedical CRO Growth Trends by Region
- 1.5.1 Global Biomedical CRO Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biomedical CRO Market Size by Region (2021-2026)
- 1.5.3 Biomedical CRO Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biomedical CRO Market Dynamics
- 2.1 Biomedical CRO Industry Trends
- 2.2 Biomedical CRO Industry Drivers
- 2.3 Biomedical CRO Industry Opportunities and Challenges
- 2.4 Biomedical CRO Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biomedical CRO Revenue by Company (2021-2026)
- 3.2 Global Biomedical CRO Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biomedical CRO Key Company Head office and Area Served
- 3.4 Global Biomedical CRO Company, Product Type & Application
- 3.5 Global Biomedical CRO Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biomedical CRO Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biomedical CRO Players Market Share by Revenue in 2025
- 3.6.3 2025 Biomedical CRO Tier 1, Tier 2, and Tier 3
4 Biomedical CRO Market by Type
- 4.1 Global Biomedical CRO Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biomedical CRO Market Size by Type (2021-2032)
- 4.3 Global Biomedical CRO Market Size Share by Type (2021-2032)
5 Biomedical CRO Market by Application
- 5.1 Global Biomedical CRO Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biomedical CRO Market Size by Application (2021-2032)
- 5.3 Global Biomedical CRO Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Charles River
- 6.1.1 Charles River Company Information
- 6.1.2 Charles River Business Overview
- 6.1.3 Charles River Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Charles River Biomedical CRO Product Portfolio
- 6.1.5 Charles River Recent Developments
- 6.2 Wuxi AppTec
- 6.2.1 Wuxi AppTec Company Information
- 6.2.2 Wuxi AppTec Business Overview
- 6.2.3 Wuxi AppTec Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Wuxi AppTec Biomedical CRO Product Portfolio
- 6.2.5 Wuxi AppTec Recent Developments
- 6.3 Labcorp
- 6.3.1 Labcorp Company Information
- 6.3.2 Labcorp Business Overview
- 6.3.3 Labcorp Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Labcorp Biomedical CRO Product Portfolio
- 6.3.5 Labcorp Recent Developments
- 6.4 Eurofins Scientific
- 6.4.1 Eurofins Scientific Company Information
- 6.4.2 Eurofins Scientific Business Overview
- 6.4.3 Eurofins Scientific Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Eurofins Scientific Biomedical CRO Product Portfolio
- 6.4.5 Eurofins Scientific Recent Developments
- 6.5 PPD
- 6.5.1 PPD Company Information
- 6.5.2 PPD Business Overview
- 6.5.3 PPD Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 PPD Biomedical CRO Product Portfolio
- 6.5.5 PPD Recent Developments
- 6.6 ICON Plc
- 6.6.1 ICON Plc Company Information
- 6.6.2 ICON Plc Business Overview
- 6.6.3 ICON Plc Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 ICON Plc Biomedical CRO Product Portfolio
- 6.6.5 ICON Plc Recent Developments
- 6.7 Pharmaron
- 6.7.1 Pharmaron Company Information
- 6.7.2 Pharmaron Business Overview
- 6.7.3 Pharmaron Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Pharmaron Biomedical CRO Product Portfolio
- 6.7.5 Pharmaron Recent Developments
- 6.8 Inotiv
- 6.8.1 Inotiv Company Information
- 6.8.2 Inotiv Business Overview
- 6.8.3 Inotiv Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Inotiv Biomedical CRO Product Portfolio
- 6.8.5 Inotiv Recent Developments
- 6.9 ChemPartner
- 6.9.1 ChemPartner Company Information
- 6.9.2 ChemPartner Business Overview
- 6.9.3 ChemPartner Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 ChemPartner Biomedical CRO Product Portfolio
- 6.9.5 ChemPartner Recent Developments
- 6.10 JOINN Lab
- 6.10.1 JOINN Lab Company Information
- 6.10.2 JOINN Lab Business Overview
- 6.10.3 JOINN Lab Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 JOINN Lab Biomedical CRO Product Portfolio
- 6.10.5 JOINN Lab Recent Developments
- 6.11 EVOTEC
- 6.11.1 EVOTEC Company Information
- 6.11.2 EVOTEC Business Overview
- 6.11.3 EVOTEC Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 EVOTEC Biomedical CRO Product Portfolio
- 6.11.5 EVOTEC Recent Developments
- 6.12 Medicilon
- 6.12.1 Medicilon Company Information
- 6.12.2 Medicilon Business Overview
- 6.12.3 Medicilon Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Medicilon Biomedical CRO Product Portfolio
- 6.12.5 Medicilon Recent Developments
- 6.13 Crown Bioscience
- 6.13.1 Crown Bioscience Company Information
- 6.13.2 Crown Bioscience Business Overview
- 6.13.3 Crown Bioscience Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Crown Bioscience Biomedical CRO Product Portfolio
- 6.13.5 Crown Bioscience Recent Developments
- 6.14 Champion Oncology
- 6.14.1 Champion Oncology Company Information
- 6.14.2 Champion Oncology Business Overview
- 6.14.3 Champion Oncology Biomedical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Champion Oncology Biomedical CRO Product Portfolio
- 6.14.5 Champion Oncology Recent Developments
7 North America
- 7.1 North America Biomedical CRO Market Size (2021-2032)
- 7.2 North America Biomedical CRO Market Size by Type
- 7.2.1 North America Biomedical CRO Market Size by Type (2021-2026)
- 7.2.2 North America Biomedical CRO Market Size by Type (2027-2032)
- 7.2.3 North America Biomedical CRO Market Share by Type (2021-2032)
- 7.3 North America Biomedical CRO Market Size by Application
- 7.3.1 North America Biomedical CRO Market Size by Application (2021-2026)
- 7.3.2 North America Biomedical CRO Market Size by Application (2027-2032)
- 7.3.3 North America Biomedical CRO Market Share by Application (2021-2032)
- 7.4 North America Biomedical CRO Market Size by Country
- 7.4.1 North America Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biomedical CRO Market Size by Country (2021-2026)
- 7.4.3 North America Biomedical CRO Market Size by Country (2027-2032)
- 7.4.4 North America Biomedical CRO Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biomedical CRO Market Size (2021-2032)
- 8.2 Europe Biomedical CRO Market Size by Type
- 8.2.1 Europe Biomedical CRO Market Size by Type (2021-2026)
- 8.2.2 Europe Biomedical CRO Market Size by Type (2027-2032)
- 8.2.3 Europe Biomedical CRO Market Share by Type (2021-2032)
- 8.3 Europe Biomedical CRO Market Size by Application
- 8.3.1 Europe Biomedical CRO Market Size by Application (2021-2026)
- 8.3.2 Europe Biomedical CRO Market Size by Application (2027-2032)
- 8.3.3 Europe Biomedical CRO Market Share by Application (2021-2032)
- 8.4 Europe Biomedical CRO Market Size by Country
- 8.4.1 Europe Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biomedical CRO Market Size by Country (2021-2026)
- 8.4.3 Europe Biomedical CRO Market Size by Country (2027-2032)
- 8.4.4 Europe Biomedical CRO Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biomedical CRO Market Size (2021-2032)
- 9.2 China Biomedical CRO Market Size by Type
- 9.2.1 China Biomedical CRO Market Size by Type (2021-2026)
- 9.2.2 China Biomedical CRO Market Size by Type (2027-2032)
- 9.2.3 China Biomedical CRO Market Share by Type (2021-2032)
- 9.3 China Biomedical CRO Market Size by Application
- 9.3.1 China Biomedical CRO Market Size by Application (2021-2026)
- 9.3.2 China Biomedical CRO Market Size by Application (2027-2032)
- 9.3.3 China Biomedical CRO Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biomedical CRO Market Size (2021-2032)
- 10.2 Asia Biomedical CRO Market Size by Type
- 10.2.1 Asia Biomedical CRO Market Size by Type (2021-2026)
- 10.2.2 Asia Biomedical CRO Market Size by Type (2027-2032)
- 10.2.3 Asia Biomedical CRO Market Share by Type (2021-2032)
- 10.3 Asia Biomedical CRO Market Size by Application
- 10.3.1 Asia Biomedical CRO Market Size by Application (2021-2026)
- 10.3.2 Asia Biomedical CRO Market Size by Application (2027-2032)
- 10.3.3 Asia Biomedical CRO Market Share by Application (2021-2032)
- 10.4 Asia Biomedical CRO Market Size by Country
- 10.4.1 Asia Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biomedical CRO Market Size by Country (2021-2026)
- 10.4.3 Asia Biomedical CRO Market Size by Country (2027-2032)
- 10.4.4 Asia Biomedical CRO Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biomedical CRO Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biomedical CRO Market Size by Type
- 11.2.1 South America, Middle East & Africa Biomedical CRO Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biomedical CRO Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biomedical CRO Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biomedical CRO Market Size by Application
- 11.3.1 South America, Middle East & Africa Biomedical CRO Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biomedical CRO Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biomedical CRO Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biomedical CRO Market Size by Country
- 11.4.1 South America, Middle East & Africa Biomedical CRO Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biomedical CRO Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biomedical CRO Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biomedical CRO Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst